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In recent years, the health-promoting effects of the citrus flavanone naringenin have been examined. The results have provided
evidence for the modulation of some key mechanisms involved in cellular damage by this compound. In particular, naringenin has
been revealed to have protective properties such as an antioxidant effect in cardiometabolic disorders. Very recently, beneficial
effects of naringenin have been demonstrated in old rats. Because aging has been demonstrated to be directly related to the
occurrence of cardiac disorders, in the present study, the ability of naringenin to prevent cardiac cell senescence was investigated.
For this purpose, a cellular model of senescent myocardial cells was set up and evaluated using colorimetric, fluorimetric, and
immunometric techniques. Relevant cellular senescence markers, such as X-gal staining, cell cycle regulator levels, and the
percentage of cell cycle-arrested cells, were found to be reduced in the presence of naringenin. In addition, cardiac markers of
aging-induced damage, including radical oxidative species levels, mitochondrial metabolic activity, mitochondrial calcium buffer
capacity, and estrogenic signaling functions, were also modulated by the compound. These results suggested that naringenin has
antiaging effects on myocardial cells.
1. Introduction
Naringenin (Nar), a bitter flavanone mainly present in citrus
fruits and tomatoes, is a common component of the human
diet. Recently, this compound has received considerable
attention for its health-promoting and disease-preventing
effects, and interest in its pharmaceutical and nutritional
effects has also increased [1]. Among the many biological
targets andmolecularmechanisms that underlie its beneficial
activities, its antioxidant actions are the best characterized.
Nar is a free radical scavenger, a metal ion chelator, and an
activator of the antioxidant enzyme defense [1, 2]. In addi-
tion, Nar stimulates the mitochondrial calcium-dependent
potassium channel (mitoBKCa), which causes an influx of
potassium ions, a mild depolarization, and a decrease in the
mitochondrial matrix calcium uptake, all of which contribute
to stabilizing the mitochondria during cellular damage [3,
4]. Furthermore, Nar has been demonstrated to bind to
estrogen receptors [5–8] and shows bidirectional adjusting
effects [9]. On the basis of these activities, it has been
suggested that this compound could be useful as a dietary
component during cardiometabolic disorders, also associated
with estrogen deficiency [10, 11]. The cardioprotective effects
ofNar arewell documented in the healthy state, inmyocardial
infarction, and in daunorubicin-, doxorubicin-, and high-
glucose-induced cardiotoxicity [2, 12–17]. A very recent
publication has also provided evidence thatNar has beneficial
effects in the livers of old rats [18]. Because aging has been
demonstrated to be directly related to the occurrence of
cardiac disorders, together, the data have prompted us to
investigate the effects of Nar in a cellular model of aged
myocardial cells. To the best of our knowledge, the effect of
Nar in cardiac cell senescence has not yet been studied.
An in vitro model of premature myocardial senescence
was established as previously reported [19]. The studies were
carried out in the absence and in the presence of Nar.
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Figure 1: (a) The structure of Nar. (b) Schematic depiction of the cell culture treatment protocol.
Various cellular senescence hallmarks (the percentage of X-
gal staining cells, the mRNA levels of the p16 and p21 cell
cycle regulators, and the percentage of cell cycle-arrested
cells) were investigated. In addition, some pathways that
are typically altered during cardiac aging-induced damage,
including the generation of radical oxidative species, the
mitochondrial metabolic activity, the modulation of the
mitochondrial calcium buffering capacity, and the regulation
of estradiol and estrogen-regulated gene expression, were
investigated [20–22].
The results demonstrated that Nar exerts effective antiag-
ing properties in myocardial cells.
2. Materials and Methods
2.1. Chemicals. Nar (5,7-dihydroxy-2-(4-hydroxy-phe-
nyl)chroman-4-one) (Figure 1(a)) and paxilline were pur-
chased from Sigma-Aldrich (Milan, Italy). They were dis-
solved (10−2M) in DMSO and further diluted in cell culture
medium. All other reagents were purchased from standard
sources.
2.2. Cell Culture. H9c2 cells (ATTC, Manassas, VA, USA),
a subclonal cell line that was derived from embryonic rat
hearts [23], were cultured in DMEM (Sigma-Aldrich, Milan,
Italy), supplemented with 10% fetal bovine serum (FBS,
Sigma-Aldrich, Milan, Italy), 100 units/mL penicillin, and
100mg/mL streptomycin in tissue culture flasks at 37∘C in a
humidified atmosphere of 5% CO
2
.
2.3. H9c2 Cell Senescence Model. H9c2 cell senescence was
induced by the exogenous oxidative insultH
2
O
2
as previously
reported [19]. Briefly, the cells were seeded at a density of 10
× 103 cells/cm2. After 24 h to allow cell attachment, the cells
were treated with vehicle (water) or various concentrations
of hydrogen peroxide (H
2
O
2
) (5–100 𝜇M) for 3 hours and
subsequently cultured for 3 days, after which the senescence
hallmarks were determined (Figure 1(b)). In parallel, low-
micromolar concentrations (4 and 40𝜇M) of Nar or vehicle
(0.1% DMSO) were added to the cells immediately after the
senescence insult and maintained in the medium for 3 days.
2.4. Senescence-Associated 𝛽-Galactosidase (sa-𝛽-Gal) Stain-
ing. To evaluate the percentage of senescent cells 3 days after
the H
2
O
2
insult, staining for the senescence marker sa-𝛽-gal
was performed as previously reported [25]. Briefly, the treated
cells were fixed in p-formaldehyde and incubated in staining
solution for 16 hours (37∘C, dry incubator). The cells were
then washed in PBS (1x), and images of randomly selected
lightmicroscopic fields were captured (5 fields per well, 100x).
Both blue (senescent) and uncolored (nonsenescent) cells
were counted using ImageJ (ImageJ Software, version 1.41,
USA).
2.5. RNA Extraction and Real-Time PCR Analysis. H
2
O
2
-
injured H9c2 cells were collected, and total RNA was
extracted using the RNeasyMini Kit (Qiagen, Hilden, Ger-
many) according to the manufacturer’s instructions. cDNA
synthesis was performed (500 ng of RNA) using the i-Script
cDNA synthesis kit (BioRad, Hercules, USA). Real-time
RT-PCR reactions (25 𝜇L, Fluocycle II SYBR [Euroclone,
Milan, Italy], 1.5 𝜇L of 10 𝜇M forward and reverse primers
for the p16 and p21 cell cycle regulators (Sigma-Aldrich,
Milan, Italy), 3 𝜇L cDNA, and 19𝜇L H
2
O) were performed
for 38 cycles using the following temperature profiles: 94∘C
for 1 minute (initial denaturation); 55–59∘C for 30 seconds
(annealing); and 72∘C for 1 second (extension).
Furthermore, the same real-time RT-PCR reactions were
performed to assess the expression of two estrogen-regulated
genes; estrogen receptor 𝛽 (ER 𝛽) and vitamin D receptor
(VDR) were studied as indicators of estrogenic activity [26].
The list of primers used in the study was shown in Table 1.
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Table 1: Nucleotide sequences, annealing temperature, and product size of the primers utilized in real-time RT-PCR experiments.
Gene Primer nucleotide sequences Annealingtemperature (∘C)
Product size
(base pairs)
p16 FOR 5
󸀠- CCGAGAGGAAGGCGAACTC -3󸀠 66.3 76
REV 5󸀠- GCTGCCCTGGCTAGTCTATCTG -3󸀠 66.2
p21 FOR 5
󸀠- GAGCAAAGTATGCCGTCGTC -3󸀠 64.7 127
REV 5󸀠- CTCAGTGGCGAAGTCAAAGTTC -3󸀠 65.0
ER 𝛽 FOR 5
󸀠- CTACAGAGAGATGGTCAAAAGTGGA -3󸀠 64.4 218
REV 5󸀠- GGGCAAGGAGACAGAAAGTAAGT -3󸀠 63.6
VDR FOR 5
󸀠- GTGACTTTGACCGGAACGTG -3󸀠 65.6 280
REV 5󸀠- ATCATCTCCCTCTTACGCTG -3󸀠 60.8
2.6. Cell Cycle Analysis. The percentages of H
2
O
2
-injured
cells in the various cell phases were determined using
the Muse Cell Cycle reagent (Merck KGaA, Darmstadt,
Germany). Briefly, senescent adherent cells were collected
and centrifuged at 300×g for 5 minutes. The pellet was
washed with PBS and suspended in 100 𝜇L of PBS and then
slowly added to 1mL of ice-cold 70% ethanol andmaintained
overnight at −20∘C.Then, an aliquot of the cell suspension (2
× 105 cells) was centrifuged, washed with PBS, suspended in
the nuclear DNA stain, propidium iodide, and analyzed [27].
2.7. ROS Production. TheROS generation was assessed using
the fluorogenic probe DCFH
2
-DA (Molecular Probes, Invit-
rogen) [19, 28]. Briefly, injured H9c2 cells, treated with Nar
or vehicle, were washed in PBS/10mM glucose (loading
buffer) and loaded with 8𝜇M DCFH
2
-DA for 30min in
the dark (37∘C). The cells were then washed and incubated
in loading buffer. FDA fluorescence was estimated using a
plate reader with wavelengths of 485 nm (excitation) and
520 nm (emission) (Wallac, Victor 2, 1420 multilabel counter,
PerkinElmer) 30 minutes later. Then, after washing with
PBS/10mMglucose, the cells were incubatedwith crystal vio-
let for 30min at room temperature. After extensive washing,
a solution of 1% SDS was added to each well, the plates were
mechanically shaken for 1 h, and the absorbance at 595 nm
was determined. The DCFH
2
-DA fluorescence values were
normalized to the cell content of each well as indicated by the
crystal violet assay.
2.8. Comet Assay. The DNA damage was assessed using the
Comet assay as previously reported [29]. Briefly, microscope
slides were coated with 0.5% normal-melting-point-agarose
(NMA) in calcium- and magnesium-free PBS, covered with
a coverslip, and kept at 4∘C in a humid box until use.
H9c2 cell suspensions (5 × 103 cells) were added to 1%
low-melting-point agarose (LMPA, 35∘C). A volume of the
LMPA-embedded sample was layered over the NMA layer.
After the agarose solidified, a final layer of 1% LMPA was
added. Following the solidification of this layer of agarose,
the coverslips were removed and the slides were treated with
lysing solution (10% DMSO, 1% TRITON X-100, 2.5M NaCl,
100mMEDTA, 10mMTRIS, and 1% sodium sarcosinate, pH
10) for 1 h at 4∘C in the dark.The slides were rinsed in distilled
water and placed in a horizontal gel electrophoresis apparatus
containing 75mMNaOHand 1mMEDTA, pH 12, for 20min.
Electrophoresis was carried out at 25V and 300mA for
10min. The slides were then removed and incubated in
neutralizing solution (0.4MTRIS, pH 7.5, 5min) three times.
The slides were drained, stained with ethidium bromide,
and observed using a fluorescence microscope (400x). The
amount of damaged DNA (migrated in the tail, Comet) was
expressed as percent of total fluorescence for each nucleus. To
calculate the distribution of DNA damage, the comets were
classified into five categories according to the percent of the
DNA in the tail: class I: 0–6% (no damage); class II: 6.1–17%
(low damage); class III: 17.1–35% (moderate damage); class
IV: 35.1–60% (high damage); and class V: 60.1–100% (extreme
damage) [30].
2.9. Mitochondrial Metabolic Activity. Briefly, the mito-
chondrial metabolic activity of senescent H9c2 cells that had
been treated with Nar or vehicle was determined using the
[3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenol)-
2-(4-sulfophenyl)-2H-tetrazolium, inner salt] (MTS) assay
according to manufacturer’s instructions (Promega, Milano,
Italy) [31]. This tetrazolium dye can be reduced by the
metabolic reducing agents NADH and NADPH to a water-
soluble formazan salt; the amount of formazan produced
is considered to be a marker of the oxidative metabolic
activity index [32]. MTS reagent was added to the PIGA
ligand-treated cells, and the colorimetric MTS conversion
was quantified after 2 h by measuring the absorbance at
490 nm using a microplate reader (WallacVictor 2, 1420
Multilabel Counter, Perkin Elmer, USA).
2.10. Calcium Retention Capacity Measurement. The calcium
retention capacity (CRC) was determined as previously
described [33] using Calcium Green-5N (𝜆ex = 505 nm,
𝜆em = 535 nm), a low affinity nonmembrane-permeant
probe that increases its fluorescence emission upon binding
Ca2+. Senescent H9c2 cells (2 × 106 cells) were suspended
in CRC buffer (250mM sucrose, 1mM Pi-Tris, and 10mM
MOPS-Tris, pH 7.4), permeabilized with digitonin (40 𝜇M,
for 5min, 0∘C), and incubated with the respiratory substrate
5mM succinate and 0.25 𝜇M Calcium Green-5 N (25∘C).
Ca2+ pulses (10 nmoles) were added at 3-minute intervals
until the onset of the permeability transition, in the presence
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or absence of Nar. To evaluate the involvement of mitoBKCa
channels in the CRC modulation, the selective mitoBKCa
blocker paxilline was applied.The fluorescence wasmeasured
using a microplate fluorimeter equipped with thermostatic
control (VictorWallac 2, Perkin Elmer, CA, USA).The results
are presented as the sample CRC normalized to the CRC of
the control (CRC
0
).
2.11. Estradiol Levels in the Conditioned Cell Medium. The
amounts of estradiol in the conditioned medium of senes-
cent H9c2 cells that had been treated with Nar or vehicle
were measured using a competitive EIA assay according to
the manufacturer’s instructions (Estradiol EIA Kit, Cayman
Chemical, Ann Arbor, MI, USA). The absorbance data
obtained from the standard curve and the cell supernatants
were plotted as logit B/B
0
versus log concentration and fit
using a linear model. To monitor the possible interference
of Nar in the assay, standard curves in the presence of Nar
concentrations were also performed.
2.12. Statistical Analyses. The nonlinear multipurpose curve-
fitting program GraphPad Prism (GraphPad Software Inc.,
San Diego, CA) was used for the data analysis and graphic
presentations. All results are presented as the means ±
standard errors of the means (SEM) of data for triplicate
samples and are representative of three different experiments.
The statistical analyses were performed using a 𝑡-test or
one-way analysis of variance (ANOVA) with Bonferroni’s
corrected 𝑡-test for post hoc pair-wise comparisons. 𝑝 < 0.05
was considered statistically significant.
3. Results and Discussion
Several epidemiological studies have suggested an inverse
correlation between aging-associated disorders, in particular
cardiovascular diseases, and the intake of citrus fruits [34,
35]. Grapefruit, bergamot, and sour oranges contain high
amounts of the flavanone-7-O-glycoside naringin, which is
metabolized by the human gutmicroflora to the aglyconeNar
[36] (Figure 1(a)). It has been estimated that themean peak of
the plasma levels of Nar reaches micromolar concentrations
following consumption of a serving of citrus fruit [37–39].
Various pharmacological effects including antimutagenic,
antiatherogenic, antihypertensive, and anti-inflammatory
activities have been reported for Nar [40–44]. Recently, the
prevention of cell death by flavanone has been studied in
H9c2 myocardial cells that were injured by exposure to a
high concentration of glucose or to daunorubicin.The results
have suggested that Nar significantly ameliorates the drug-
induced toxicity by inhibiting apoptosis [1, 2]. A very recent
publication has demonstrated that Nar has the ability to
improve the antioxidant status and membrane phospholipid
composition in old rats [18]. These data prompted us to
investigate the effects of Nar in a cellular model of aged
myocardial cells.
3.1. Senescence-Associated 𝛽-Galactosidase Staining and Cell
Cycle Investigations. In the present study, the cellular senes-
cence model that was used to assess the cardioprotective
action of Nar was established with H9c2 cells that were
exposed to H
2
O
2
to induce senescence. Despite their embry-
onic origin, H9c2 cells are similar to normal primary car-
diomyocytes with respect to their energy metabolism and
have been successfully used as an in vitro model for studies
ofmyocardial pathophysiology, including the aging processes
[19, 45–49].
Myocardial cellular senescence was triggered by exposing
the cells toH
2
O
2
as previously reported [19], and the presence
of sa-𝛽-gal product was monitored as a marker of cellular
senescence. To establish the effective dose ofH
2
O
2
, H9c2 cells
were exposed to a range of concentrations of H
2
O
2
(from
5 𝜇M to 100 𝜇M) for 3 hours and subsequently cultured with
fresh complete medium for 72 h (Figure 1(b)).
The presence of sa-𝛽-gal product after H
2
O
2
incuba-
tions was examined (Figure 2). A concentration-dependent
increase in the sa-𝛽-gal activity was observed in the H
2
O
2
-
exposed cells; the 60𝜇M H
2
O
2
concentration effectively
induced significant staining for sa-𝛽-gal (𝑝 < 0.01, Fig-
ure 2(a)). A higher dose of H
2
O
2
(100 𝜇M) did not further
increase the senescence marker, probably due to its cytotoxic
effect (data not shown). Thus, the 60 𝜇M concentration of
H
2
O
2
was established as the effective drug concentration
(𝐸max) for use in the cell treatment protocol as shown in
Figure 1.
The cell cycle regulators p16 and p21, which are mainly
activated during the senescence process, and the percentage
of cells in the various cell cycle phases were then evaluated.
The real-time RT-PCR results showed that the H
2
O
2
cell
treatments significantly increased the levels of p16 and p21
mRNA (𝑝 < 0.01 and 𝑝 < 0.001, Figure 2(d)). Consistent
with these results, the cell cycle analysis demonstrated that
the cell cycle was arrested in G2/M phase following H
2
O
2
treatment (𝑝 < 0.001, Figure 2(e)). All of these results
are consistent with the literature [19, 50–54]. Specifically,
previous studies have demonstrated that the number of
senescent cells as indicated by X-gal staining and the p21 cell
cycle regulator are increased in a dose-dependent manner
by treatment with H
2
O
2
and that the cell cycle is arrested at
the G1 and G2/M phases [19, 53]. Furthermore, it has been
demonstrated that challenge of H9c2 cells withH
2
O
2
induces
a significant increase in the intracellular ROS level and in
the olive tail moment, which indicates an increase in DNA
damage [19].
Therefore, H9c2 cells were challenged with 60 𝜇M H
2
O
2
for 3 hours and then cultured with fresh complete medium
containing various concentrations of Nar. Senescence hall-
marks were assessed 72 h later (Figure 2(b)).
Treatment with 40 𝜇M Nar significantly protected the
cells from the senescence-inducing insult; specifically, it
decreased the number of sa-𝛽-gal positive cells (𝑝 < 0.01,
Figures 2(b) and 2(c)). In contrast, treatment with 4𝜇M
Nar failed to prevent the development of cellular senes-
cence, although a trend for a reduction in the number of
senescent cells was evident (Figure 2(b)). Thus, the 40 𝜇M
concentration was selected for subsequent assays. Notably,
previous human pharmacokinetic analyses have shown that
Nar, following a single oral administration of 135mg (equal
to 1 or 2 glasses of grapefruit juice), is rapidly absorbed and
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Figure 2: Nar effects on H9c2 cell senescence hallmarks. (a) Senescence-associated b-galactosidase staining. The data are shown as the
percentages of 𝛽-galactosidase-positive cells. Each bar represents the mean ± SEM of three replicates from three independent experiments.
∗∗∗𝑝 < 0.01 versus the control group; (b) the data are shown as percentage of 𝛽-galactosidase-positive cells. Each bar represents the mean
± SEM of three replicates from three independent experiments. ∗∗𝑝 < 0.01 versus the H
2
O
2
-treated cells. (c) Representative phase contrast
photomicrographs of treated cells; (A) H
2
O
2
-treated cells; (B) 40𝜇M Nar-cotreated cells. (d, e) Cell cycle arrest machinery. (d) p16 and p21
mRNA fold induction. Each bar represents the mean ± SEM of three replicates from three independent experiments. ∗∗∗𝑝 < 0.001 versus
the control group; ###𝑝 < 0.001 versus the H
2
O
2
-treated group. (e) Cell cycle phases. Each bar represents the mean ± SEM of three replicates
from three independent experiments. ∘∘∘𝑝 < 0.001 versus the control group; ∗∗𝑝 < 0.01 versus the H
2
O
2
-treated group.
its concentration in plasma reaches a peak of approximately
10 𝜇M in 3.5 hours [27, 55]. Furthermore, Nar cotreatment
abolished the increase in p16 and p21 mRNA due to H
2
O
2
(𝑝 < 0.01 and 𝑝 < 0.001, Figure 2(d)) and reduced the cell
cycle arrest in G2/M (𝑝 < 0.01, Figure 2(e)).
Collectively, the present data showed for the first time that
Nar treatment counteracts the manifestation of the senescent
hallmarks in H
2
O
2
-treated cells, which suggests that it has
the ability to prevent the prematurely induced senescence in
H9c2 cells. In a very recent review, Nar was identified as an
6 Oxidative Medicine and Cellular Longevity
0
50
100
150
###
RO
S 
ge
ne
ra
tio
n
(%
 o
f c
on
tro
l fl
uo
re
sc
en
ce
 in
te
ns
ity
)
D
M
SO
H
2
O
2
6
0
𝜇
M
H
2
O
2
+
N
ar
4
0
𝜇
M
∗∗∗
(a)
H2O2 + Nar 40 𝜇MControl H2O2
(b)
1 2 3 4 5 1 2 3 4 5 1 2 3 4 5
0
20
40
60
80
##
#
##
### ##
DNA damage class
%
 H
9c
2 
ce
lls
H2O2 + Nar
∗∗∗
∗∗
∗∗∗
∗∗∗
∗∗∗
Control H2O2
(c)
Figure 3: ROS production and DNA damage. (a) ROS generation in H9c2 cells. Each bar represents the mean ± SEM of three replicates from
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-treated cells. (b) Representative
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2
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-treated cells.
effective antiaging ingredient among the traditional Chinese
medicine natural products [56]. This hypothesis has been
proposed based on the activity of Nar to increase glucose
uptake in skeletal muscle cells through activation of AMPK
[57]. In addition, the recent data obtained using old rats have
confirmed this assumption. Indeed, flavanone administration
to old male rats was able to modulate the activity of antiox-
idant enzymes including catalase, superoxide dismutase 1,
and glutathione reductase. All of these enzymes significantly
decrease during aging, and their activities were found to
be increased in flavanone-fed old rats compared to vehicle-
treated animals. Furthermore, thiobarbituric acid reactive
substances (TBARS) were significantly decreased by Nar
administration, and the membrane phospholipid composi-
tion was improved in favor of 𝜔-3 PUFA and the 𝜔-6/𝜔-3
PUFA ratio [18].
3.2. Nar Reduced ROS Generation and DNA Damage. In
this context, among the pathways typically impaired during
cardiac aging-associated damage, the cellular mechanisms
associated with the generation of radical oxidative species
(ROS) generation and alterations in DNA integrity are fre-
quently altered [58, 59]. These parameters were therefore
assessed in our model. As shown in Figure 3, H
2
O
2
treatment
caused a significant increase in ROS generation (𝑝 < 0.001,
Figure 3(a)), and cotreatment of the cells with Nar resulted in
maintenance of the ROS levels as those of the control (𝑝 <
0.001 versus cells treated with H
2
O
2
alone).
Consistent with the ROS results, the DNA damage
assessed using the Comet assay was increased in the H
2
O
2
-
exposed H9c2 cells (Figures 3(b) and 3(c)). Specifically,
senescent cells demonstrated moderate/high DNA damage
(corresponding to classes 3, 4, and 5) compared to control
cells (𝑝 < 0.5, 𝑝 < 0.1, and 𝑝 < 0.001, Figure 3(c)). Notably,
in the Nar-treated senescent cells, the reduction in the high
numbers of cells with moderate/high DNA damage (classes
3, 4, and 5, 𝑝 < 0.1, 𝑝 < 0.001, and 𝑝 < 0.1 versus the
H
2
O
2
-treated cells, resp.) suggested a protective activity of
Nar against ROS-induced genotoxic damage (Figure 3(c)).
It was indirectly shown that the reduction of both ROS
and DNA damage is a result of Nar effect on antioxidative
enzyme activity or by scavenger function. These results are
consistent with previous studies that were carried out using
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the skin of hairless mice in which UVB irradiation was
used to induce oxidative stress and premature aging [60].
Nar has been shown to mitigate UVB irradiation-induced
oxidative stress by reducing superoxide anion production and
the mRNA expression of a subunit of NADPH oxidase [60].
3.3. Nar Modulated the Mitochondrial Metabolic Activity and
Increased theCalciumRetentionCapacity. Additional cellular
mechanisms that are often impaired during aging processes
include those related to mitochondrial homeostasis [61–
63]. Cellular senescence and mitochondrial dysfunction are
hallmarks of aging; recent works have shown that mito-
chondrial defects can even cause a distinct senescence phe-
notype termed mitochondrial dysfunction-associated senes-
cence [62, 63]. The roles of the mitochondrial electron
transport chain, bioenergetic balance, redox state, metabolic
signature, and calcium homeostasis have been recently stud-
ied in the context of the control of cellular growth arrest
that is associated with senescence. These studies indicated
that multiple mitochondrial signaling pathways in addition
to mitochondrial ROS can induce cellular senescence [61].
Perturbation of mitochondrial homeostasis promotes the
establishment and maintenance of cellular senescence, and
various strategies to improve mitochondrial function have
emerged as therapeutic approaches to aging [64].
In this context, the mitochondrial metabolic activity was
explored in the Nar-treated H9c2 cells using a tetrazolium
dye. The results demonstrated that Nar treatment increased
the mitochondrial metabolic activity of senescent cells rel-
ative to that of the controls (𝑝 < 0.05, Figure 4(a)).
Interestingly, parallel experiments in naı¨ve H9c2 cells (not
senescent) showed that Nar did not modulate mitochondrial
metabolism per se, and it did not affect the number of
senescent cells relative to the control (data not shown).
Next, the effects of Nar on a mitochondrial parameter
recognized to be an indicator of damage resistance, the
mitochondrial Ca2+-buffering cell capacity, were assessed.
In particular, the mitochondrial calcium retention capacity,
CRC, was explored; the upper limit of the CRC reflects the
opening of the permeability transition pore (MPTP) and
the dissipation of mitochondrial potential [65]. As shown
in Figure 4, the cells treated with H
2
O
2
(dashed black line)
showed a significantly reduced ability to retain Ca2+ as
indicated by the decrease in the CRC/CRC
0
ratio (𝑝 < 0.05)
(Figures 4(b) and 4(c)). Cells that had previously been treated
with H
2
O
2
were used to investigate the CRC in the presence
of Nar. Nar was able to increase the mitochondrial CRC
compared to the control cells (Figure 4(d), gray line versus
dashed black line, Figure 4(e), 𝑝 < 0.01).
The present data indicated that senescent H9c2 cells were
more susceptible to the opening of the MPTP, in accordance
with previous studies on cardiomyocytes isolated from old
rats [66]. Notably, treatment of the cells with Nar was able
to reduce this altered mitochondrial sensitivity.
It has been previously demonstrated that Nar is able
to activate the mitoBKCa channels in mitochondria isolated
from young rat hearts. This produces a mild depolarization
of themembrane potential.This depolarization is responsible
for reducing the uptake of Ca2+ into themitochondrialmatrix
and preserving the mitochondria from the Ca2+ overload
and the subsequent MPTP opening [4, 14]. To evaluate the
involvement of mitoBKCa channels in the Nar-mediated CRC
effects, the selective mitoBKCa blocker paxilline was tested
in the CRC assessment. Paxilline alone had no significant
effect on the CRC (data not shown), which might indicate
that mitoBKCa channels were inactive under the resting
condition. Interestingly, consistent with the modulation of
mitoBKCa channels by Nar [14], the CRC increase exerted by
Nar was partially prevented by cotreatment of the cells with
paxilline (Figures 4(d), light gray line, and 4(e)).These results
indicated that the Nar effects on the CRCmight be mediated,
at least in part, by the activation of mitoBKCa channels.
Interestingly, it has been previously shown that the opening
of mitoBKCa channels improves the function and energetic
performance of cardiac mitochondria, which is consistent
with our results [67]. One possible explanation may be
the mild depolarization that occurs during the mitoBKCa
channel opening. Indeed, it has been demonstrated that mice
produce fewer free radicals and live longer when they have
more uncoupledmitochondria, which show a lowmembrane
potential, in muscles [68].
3.4. Nar Modulated the Levels of Estradiol Released by Cells
and the Estrogen-Regulated Gene Expression. It is well known
that estrogen is strongly implicated in cardiomyocyte survival
and that its levels varywidely based on age [69, 70]. In general,
premenopausal women are protected from coronary heart
disease compared with age-matched men, but this female
protection appears to be lost aftermenopause, which suggests
that estrogen has beneficial effects on the cardiovascular
system [22]. In addition to adrenal production of estrogen,
the synthesis of estrogen by cardiac cells has been proposed,
although this process has been very poorly elucidated (for a
review, see [71]). Interestingly, some papers have suggested
that local estrogen biosynthesis in the heart effectively acti-
vates the estrogen receptors 𝛼 and 𝛽 and downstream target
genes in a gender-based fashion [72]. For these reasons, in the
present study, the Nar effects on the estrogenic pathway were
studied in senescent H9c2 cells. Specifically, we evaluated the
estradiol released by cells and the estrogen-regulated gene
expression.
As shown in Figure 5, H
2
O
2
challenge induced a signif-
icant decrease in the levels of estradiol released by the cells
(𝑝 < 0.05). This reduction was significantly counteracted
by Nar treatment (𝑝 < 0.001 versus the H
2
O
2
-treated
cells) (Figure 5(a)). Surprisingly, the level of estradiol in Nar-
control cells (cells without H
2
O
2
challenge) was higher than
in the control cells (𝑝 < 0.001 versus control). It is reasonable
to presume that such an increase may be due to the activation
of cellular response mechanisms during the Nar treatment:
one possible explanation may be that the response is related
to cellular self-adaptive responses. Although the estrogenic
potency of Nar has been controversial [7, 73], some studies
have demonstrated the estrogenic effects of Nar andNar-type
flavonoids inmammalian in vitro systems using the estrogen-
inducible MVLN luciferase assay [74].
Furthermore, the Nar-mediated expression of some
commonly used parameters of drug estrogenic activity,
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Figure 4: Effects of H
2
O
2
and Nar on the mitochondrial oxidative metabolism activity and CRC. (a) H9c2 cells were treated with H
2
O
2
and DMSO or Nar, and the mitochondrial oxidative metabolism activity was examined. (b–e) The cells were suspended in CRC medium
and permeabilized with digitonin. To these cells, 0.25M Calcium Green-5N and 5mM succinate were added. This addition was followed
by a series of Ca2+ pulses (10 nmoles) at 3-minute intervals until onset of the permeability transition (plateau). The Relative Fluorescence
Unit (RFU) was recorded by spectrophotometer technique. ∗𝑝 < 0.05 versus DMSO-treated cells. (b) Representative traces of the H9c2 cell
treatments with H
2
O
2
and vehicle are shown in dashed black and gray, respectively. (c) The results from the H
2
O
2
-treated cells are shown
as the CRC normalized to the CRC of control (CRC
0
). The data shown are the means ± SEM of three independent experiments. ∗𝑝 < 0.05
versus vehicle. (d) Representative traces of senescent H9c2 cells cotreated with DMSO (dashed black), Nar (dark gray), and Nar + Pax (light
gray). (e) The results from senescent cells treated with Nar and Nar + Pax are shown as the CRC normalized to the CRC of control (CRC
0
).
The data shown are the means ± SEM of three independent experiments. ∗∗𝑝 < 0.01 versus DMSO-treated cells.
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Figure 5: Effect of Nar on the levels of released estradiol and estrogen-regulated gene mRNA expression. (a) Each bar represents the mean
± SEM of three replicates from three independent experiments. The measured estradiol levels were within the reference range [24]. Specific
calibration curves and appropriate positive/negative controls were carried out during the assay. ∗𝑝 < 0.05 and ∗∗∗𝑝 < 0.001 versus the control;
###𝑝 < 0.001 versus H
2
O
2
-treated cells. (b) ER 𝛽 and (c) VDR mRNA expression as indicators of estrogenic activity in the senescent H9c2
cells. Each bar represents the mean ± SEM of three replicates from three independent experiments. ∗𝑝 < 0.05, ∗∗𝑝 < 0.01, and ∗∗∗𝑝 < 0.001
versus the control; #𝑝 < 0.05 and ##𝑝 < 0.01 versus H
2
O
2
-treated cells.
specifically the estrogen-regulated genes ER 𝛽 and VDR,
was investigated. Quantitative real-time PCR experiments
demonstrated that the expression of the ER𝛽 and VDR
mRNA was significantly reduced in H
2
O
2
-treated cells (𝑝 <
0.01, Figure 5(b)) and that Nar was able to prevent this
decrease (𝑝 < 0.01 versus the H
2
O
2
-treated cells). Consistent
with the estradiol results, mRNA expression of both of these
genes was increased by the Nar-only treatment.
Together, these data suggested that the ability of Nar to
counterbalance the effects of H
2
O
2
on the estrogenic pathway
may contribute to its antisenescence effects.
4. Conclusions
In conclusion, Nar treatment of H9c2 cells prevented the
prematurely induced senescence; Nar protectionmay involve
10 Oxidative Medicine and Cellular Longevity
multiple cellular pathways on the basis that it modulated
the ROS levels, the mitochondrial potassium channels, and
the estrogen-related pathways. In particular, the specific
pathways involved seem to be those associated with themito-
chondria.These results pave the way to exciting nutraceutical
advances.
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